AdvanSource Biomaterials Corporation (OTCMKTS:ASNB) Files An 8-K Other Events
Item 8.01. Other Events.
On November 25, 2019, the Company issued a press release announcing the entry into the Purchase Agreement. A copy of the press release is attached as Exhibit 99.1 and is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
| 99.1 | Press Release issued November 25, 2019. |
AdvanSource Biomaterials Corp Exhibit
EX-99.1 2 f8k112519ex99-1_advansource.htm PRESS RELEASE ISSUED NOVEMBER 25,…
To view the full exhibit click here
About AdvanSource Biomaterials Corporation (OTCMKTS:ASNB)
AdvanSource Biomaterials Corporation develops polymer materials. The Company’s biomaterials are used in devices that are designed for treating a range of anatomical sites and disease states. The Company manufactures and sells its polymers under the trade names, including ChronoFilm, ChronoFlex, ChronoThane, ChronoPrene, ChronoSil, HydroThane and PolyBlend. The Company also offers HydroMed. It also manufactures specialty hydrophilic polyurethanes. It manufactures and sells its HydroThane polymers to medical device manufacturers that are evaluating HydroThane for use in their products. Its HydroThane is a thermoplastic, water-absorbing and polyurethane elastomer. It manufactures polymeric materials with a range of physical and biological properties. The Company manufactures polymeric materials with a range of physical and biological properties. The Company’s polymers are available with characteristics, such as biodurability, biocompatibility, lubricity and antimicrobial properties.
